DIH Holding US, Inc.

DHAI

Healthcare Medical Devices

DIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.

Revenue
−30.7%
EPS
+43.1%
Free cash flow
−167.9%

Quarter to March 2025, against a year earlier

0.00 0.00 NaN
Market cap
$1.6M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
−1.5×
Dividend safety
n/a
Mar '25 Dec '24 Sep '24 Jun '24 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.14 0.69 0.98 1.52
P/FCF ratio
0.00 12.93 23.71 19.91
P/Operating CF
(2.76) 69.69 137.89 (46.58)
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
0.29 0.84 1.14 1.69
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(3.89) 15.67 27.42 22.16
Current Ratio
0.49 0.51 0.60 0.61
Net Debt/EBITDA
(2.13) (4.08) 4.78 (6.79)
Debt/Equity
(0.30) (0.30) (0.36) (0.39)
Earnings Yield
(102.88%) (23.39%) (16.43%) (15.57%)
Free Cash Flow Yield
(51.53%) 7.73% 4.22% 5.02%
Free Cash Flow per Share
(2.16) 0.48 0.21 (1.62)
Book value per Share
(23.63) (27.34) (24.89) (24.60)
Free Cash Flow
(3.39) 0.67 0.29 (2.24)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026